HSIC vs TELA · P/E 24, rev $6.83B vs rev $38.4M
Henry Schein Inc (HSIC) versus Tela Bio Inc (TELA) — a side-by-side from cached financials, not a winner call.
Henry Schein Inc (HSIC) is a medical distribution company listed on NASDAQ.
Tela Bio Inc (TELA) is a medical devices company listed on NASDAQ.
Latest reported HSIC revenue for 2026-06-27 was $6.83B. Net income was $201.0M. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
Latest reported TELA revenue for 2026-06-30 was $38.4M. Net income was -$23.5M. TELA currently screens at market cap $38.5M.
HSIC currently screens at market cap $9.11B and trailing P/E 24.2. TELA currently screens at market cap $38.5M.
Not investment advice. Open the HSIC and TELA stock pages for the full models.
Not investment advice.